BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 26614866)

  • 21. Pediatric therapy-related myelodysplastic syndrome/acute myeloid leukemia: the MD Anderson Cancer Center experience.
    Aguilera DG; Vaklavas C; Tsimberidou AM; Wen S; Medeiros LJ; Corey SJ
    J Pediatr Hematol Oncol; 2009 Nov; 31(11):803-11. PubMed ID: 19801947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recent progress in acute leukemia and myelodysplasia.
    Carraway HE; Pollyea DA; Stein EM
    Best Pract Res Clin Haematol; 2022 Dec; 35(4):101415. PubMed ID: 36517125
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Parameters detected by geriatric and quality of life assessment in 195 older patients with myelodysplastic syndromes and acute myeloid leukemia are highly predictive for outcome.
    Deschler B; Ihorst G; Platzbecker U; Germing U; März E; de Figuerido M; Fritzsche K; Haas P; Salih HR; Giagounidis A; Selleslag D; Labar B; de Witte T; Wijermans P; Lübbert M
    Haematologica; 2013 Feb; 98(2):208-16. PubMed ID: 22875615
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Geriatric perspective: how to assess fitness for chemotherapy in acute myeloid leukemia.
    Klepin HD
    Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):8-13. PubMed ID: 25696829
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of oral cytarabine ocfosfate and etoposide in the treatment of elderly patients with higher-risk myelodysplastic syndromes compared to that in elderly acute myeloid leukemia patients.
    Horikoshi A; Iriyama N; Hirabayashi Y; Kodaira H; Matsukawa Y; Uchino Y; Takahashi H; Hatta Y; Takeuchi J; Kobayashi S; Miura K
    Chemotherapy; 2013; 59(2):152-8. PubMed ID: 24080768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Advance care planning in older patients with acute myeloid leukemia and myelodysplastic syndromes.
    LoCastro M; Sanapala C; Mendler JH; Norton S; Bernacki R; Carroll T; Klepin H; Watson E; Liesveld J; Huselton E; O'Dwyer K; Baran A; Flannery M; Kluger BM; Loh KP
    J Geriatr Oncol; 2023 Jan; 14(1):101374. PubMed ID: 36100548
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Molecular mechanisms of the progression of myelodysplastic syndrome to secondary acute myeloid leukaemia and implication for therapy.
    Dan C; Chi J; Wang L
    Ann Med; 2015 May; 47(3):209-17. PubMed ID: 25861829
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Age related risk of myelodysplastic syndrome and acute myeloid leukemia among breast cancer survivors.
    Kaplan HG; Malmgren JA; Li CI; Calip GS
    Breast Cancer Res Treat; 2013 Dec; 142(3):629-36. PubMed ID: 24265034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial therapy for acute myeloid leukemia in older patients: principles of care.
    Bhatt VR; Gundabolu K; Koll T; Maness LJ
    Leuk Lymphoma; 2018 Jan; 59(1):29-41. PubMed ID: 28573900
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A systematic review of patient reported outcomes in phase II or III clinical trials of myelodysplastic syndromes and acute myeloid leukemia.
    Bryant AL; Drier SW; Lee S; Bennett AV
    Leuk Res; 2018 Jul; 70():106-116. PubMed ID: 29925044
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acute coronary care in the elderly, part I: Non-ST-segment-elevation acute coronary syndromes: a scientific statement for healthcare professionals from the American Heart Association Council on Clinical Cardiology: in collaboration with the Society of Geriatric Cardiology.
    Alexander KP; Newby LK; Cannon CP; Armstrong PW; Gibler WB; Rich MW; Van de Werf F; White HD; Weaver WD; Naylor MD; Gore JM; Krumholz HM; Ohman EM; ;
    Circulation; 2007 May; 115(19):2549-69. PubMed ID: 17502590
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapy-related myelodysplastic syndrome with monosomy 5 after successful treatment of acute myeloid leukemia (M2).
    Ogasawara T; Yasuyama M; Kawauchi K
    Am J Hematol; 2005 Jun; 79(2):136-41. PubMed ID: 15929101
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Acute myeloid leukemia or myelodysplastic syndrome following use of granulocyte colony-stimulating factors during breast cancer adjuvant chemotherapy.
    Hershman D; Neugut AI; Jacobson JS; Wang J; Tsai WY; McBride R; Bennett CL; Grann VR
    J Natl Cancer Inst; 2007 Feb; 99(3):196-205. PubMed ID: 17284714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Predictors of outcome following myeloablative allo-SCT for therapy-related myelodysplastic syndrome and AML.
    Nevill TJ; Hogge DE; Toze CL; Nantel SH; Power MM; Abou Mourad YR; Song KW; Lavoie JC; Forrest DL; Barnett MJ; Shepherd JD; Nitta JY; Wong S; Sutherland HJ; Smith CA
    Bone Marrow Transplant; 2008 Nov; 42(10):659-66. PubMed ID: 18679372
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Promoter methylation of DAPK1, E-cadherin and thrombospondin-1 in de novo and therapy-related myeloid neoplasms.
    Greco M; D'Alò F; Scardocci A; Criscuolo M; Fabiani E; Guidi F; Di Ruscio A; Migliara G; Pagano L; Fianchi L; Chiusolo P; Hohaus S; Leone G; Voso MT
    Blood Cells Mol Dis; 2010 Oct; 45(3):181-5. PubMed ID: 20655775
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Impact of disease burden at time of allogeneic stem cell transplantation in adults with acute myeloid leukemia and myelodysplastic syndromes.
    Kebriaei P; Kline J; Stock W; Kasza K; Le Beau MM; Larson RA; van Besien K
    Bone Marrow Transplant; 2005 May; 35(10):965-70. PubMed ID: 15806131
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Relapsed and secondary disease drive the risk profile for invasive aspergillosis prior to stem cell transplantation in patients with acute myeloid leukemia or myelodysplastic syndrome.
    van de Peppel RJ; Dekkers OM; von dem Borne PA; de Boer MG
    Med Mycol; 2014 Oct; 52(7):699-705. PubMed ID: 25049037
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characteristics of acute myeloid leukemia with myelodysplasia-related changes: A retrospective analysis in a cohort of Chinese patients.
    Xu XQ; Wang JM; Gao L; Qiu HY; Chen L; Jia L; Hu XX; Yang JM; Ni X; Chen J; Lü SQ; Zhang WP; Song XM
    Am J Hematol; 2014 Sep; 89(9):874-81. PubMed ID: 24861848
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Transformation of myelodysplastic syndromes into acute myeloid leukemias.
    Shi J; Shao ZH; Liu H; Bai J; Cao YR; He GS; Tu MF; Wang XL; Hao YS; Yang TY; Yang CL
    Chin Med J (Engl); 2004 Jul; 117(7):963-7. PubMed ID: 15265365
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.